Haemonetics | HAE - Fremdkapital





Fremdkapital Veränderung Datum
Avanos Medical USD 87.3M 3M 2026-03
Baxter International USD 8.62B 852M 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Boston Scientific USD 11.01B 19M 2025-12
Cerus USD 64.86M 22K 2024-12
Cooper Companies USD 1.86B 17.7M 2026-03
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Globus Medical USD 436K 9K 2025-12
Haemonetics USD 1.22B 299.58M 2026-03
ICU Medical USD 1.26B 4.09M 2026-03
Intuitive Surgical USD 0 0 2025-03
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 735.16M 1.12M 2026-03
Neogen USD 793.3M 374K 2025-12
OraSure Technologies USD 100K 17K 2025-12
Plus Therapeutics USD 3.79M 322K 2022-12
Quidel USD 0 2.47B 2026-03
ResMed USD 404.17M 245K 2026-03
STAAR Surgical USD 42K 42K 2023-12
Steris USD 1.81B 85.6M 2026-03
Stryker USD 14.22B 635M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Terumo JPY 99.91B 13M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
US Physical Therapy USD 194.04M 41.45M 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03